2025 INTERNATIONAL MEETING ON ASTHMA, RHINITIS, COPD AND THEIR COMORBIDITIES 1-2 DECEMBER 2025 FIRENZE


MONDAY 1 December 2025

08:30-13:05 MEETING OF THE ITALIAN GOLD-MULTIMORBIDITY WORKING GROUP

08:30-10:30 PART I: ANNUAL MEETING OF THE ITALIAN GOLD WORKING GROUP
Charimen Antonio Spanevello, Enrico M. Clini and Federico Lavorini

08:30 2025 UPDATE OF THE GOLD REPORT
Alvar Agusti

08:50 DISCUSSION
Participants Alvar Agusti, Raffaele F. Antonelli Incalzi, Enrico M. Clini, Lorenzo Corbetta, Angelo Guido Corsico, Francesco Dentali, Claudio Micheletto, Paolo Palange, Alberto Papi, Antonio Spanevello and Members of the Working Group

11:00-13:05 PART II: LECTURES
Chairpersons Raffaele F. Antonelli Incalzi, Francesco Dentali and Marina Saetta

11:00 FROM SINGLE DISEASES TO CHRONIC AIRWAY DISEASES: THE NOVELTY STUDY
Helen K. Reddel

11:25 COMPLEXITY OF THE DIAGNOSIS OF COPD: MAJOR AND MINOR CRITERIA
Surya P. Bhatt

11:50 PERSONALIZED MANAGEMENT OF EXACERBATIONS OF RESPIRATORY SYMPTOMS IN MULTIMORBID COPD PATIENTS
Bartolome R. Celli

12:15 MANAGEMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH COPD
Jadwiga Wedzicha

12:40 PERSONALIZED MANAGEMENT OF MULTIMORBID CHRONIC AIRWAY DISEASES: ROLE OF BIOLOGICS
Alberto Papi

14:00-16:00 COLLABORATION BETWEEN ACADEMIC SCIENTISTS AND PHARMA INDUSTRY SCIENTISTS IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR ASTHMA, ALLERGY/RHINITIS, COPD, MULTIMORBIDITY
Chairmen Matteo Bonini, Leonardo M. Fabbri, Pierluigi Paggiaro, Alberto Papi, Giovanni Passalacqua and Antonio Spanevello

14:00 APPROACHING COPD SYSTEMICALLY: PATIENTS, PATHWAYS, AND PLANET
Diego Ardigò
Executive Vice President
Global Research & Development
CHIESI FARMACEUTICI

14:15 TRANSFORMING CLINICAL RESEARCH WITH AI
Gianluigi Micarelli
Medical Advisor Italy
MCO cluster
SANOFI

14:30 A GSK LOOK INTO THE FUTURE OF RESPIRATORY DISEASES
Nadia Kallinikou
European Medical Lead
Respiratory Biologics
GLAXOSMITHKLINE

14:45 DRIVING INNOVATION IN RESPIRATORY DRUG DISCOVERY
Neil Martin
Franchise Head (Vice President)
Late Respiratory & Immunology
Research & Development
ASTRAZENECA

15:00 SHIFTING THE PARADIGM FOR COPD TREATMENT: A LOOK INTO THE FUTURE
Katerina Samara
Group Lead Respiratory
ROCHE

15:15 ENSIFENTRINE: A DUAL PDE3/4 APPROACH FOR EVOLVING COPD MANAGEMENT
Kavita Aggarwal
Senior Vice President Medical Affair
VERONA PHARMA

15.30 GENERAL DISCUSSION

16:00-17:30 COPD DIAGNOSIS AND MANAGEMENT
Chairmen Claudio Micheletto, Paolo Palange and Manuel G. Cosio

16:00 BRONCHIECTASIS: INDIVIDUAL DISEASE OR COMPONENT OF CHRONIC AIRWAY DISEASES
Eva Polverino

16:30 CAN WE MODIFY THE NATURAL HYSTORY IN PATIENTS WITH MULTIMORBID COPD
Alvar Agusti

17:00 DISEASE STABILITY IN PATIENTS WITH MULTIMORBID COPD
Dave Singh

18:00-18:30 HONORARY LECTURE
Chairmen Leonardo M. Fabbri, Dario Olivieri and Alberto Papi

MUCUS PLUGS IN ASTHMA AND COPD
John V. Fahy

18:30-19:00 HONORARY LECTURE
Chairmen Eugenio Baraldi and Alberto Papi

IMMUNITY AND VACCINES: FROM SUSTAINABILITY OF THE SERVIZIO SANITARIO NAZIONALE TO GLOBAL HEALTH
Alberto Mantovani


TUESDAY 2 December 2025


08:00-10:15 MEETING OF THE ITALIAN ARIA (Rhinitis) WORKING GROUP
Chairmen Carlo Lombardi, Giovanni Paoletti and Giovanni Passalacqua

08:00 2025 UPDATE of ARIA
Giorgio Walter Canonica

08:15 WORKING GROUP DISCUSSION: BREAKINGS NEWS IN ARIA

10:15-13:15 MEETING OF THE ITALIAN GINA (Asthma) WORKING GROUP

10:15-11:35 PART 1: DISCUSSION OF THE 2025 UPDATE OF THE GINA REPORT
Chairmen Pierluigi Paggiaro, Sergio Bonini, Giorgio Walter Canonica, Fabio Luigi Massimo Ricciardolo and Nicola Alessandro Scichilone

10:15 LECTURE
Chairpersons Matteo Bonini, Stefania La Grutta and Pierluigi Paggiaro

HIGH DOSE ICS ASTHMA: NO MORE
Helen K. Reddel

10:35 DISCUSSION
Participants Bianca Beghè, Matteo Bonini, Giovanna Elisiana Carpagnano, Gianenrico Senna and Members of the Working Group

12:00-13:15 PART II: PEDIATRIC ASTHMA
Chairpersons Alessandro Fiocchi, Diego G. Peroni, Giorgio Piacentini and Francesca Santamaria

12:00 ICS/FORMOTEROL IN CHILDHOOD ASTHMA
Richard Beasley

12:25 MANAGEMENT SEVERE ASTHMA IN CHILDREN
Andrew Bush

12:50 HAS NATURAL HISTORY OF ASTHMA CHANGED IN THE LAST 50 YEARS
Erika von Mutius

14:15-16:30 SEVERE ASTHMA
Chairpersons Matteo Bonini, Sergio Bonini, Leonardo M. Fabbri and Fabio Luigi Massimo Ricciardolo

14:15 COMPLEXITY OF INFLAMMATORY MECHANISMS IN SEVERE ASTHMA AND COMORBIDITIES
Guy Brusselle

14:45 HOLISTIC APPROACH TO THE MANAGEMENT OF SEVERE ASTHMA AND ITS COMORBIDITIES
Klaus F. Rabe

15:15 TREATMENT OF ACUTE RESPIRATORY FAILURE IN ASTHMATICS
Massimo Antonelli

15:45 BIOLOGICS IN MILD/ MODERATE ASTHMA
Simon Couillard

16:15 END AND FAREWELL
Leonardo M. Fabbri